Extracellular vesicles (EVs) are rapidly gaining in popularity as biomarkers of various diseases, acting as cargoes of valuable information from the cell of origin. Despite their important value, their current use in clinical practice is still limited. One of the most limiting factors is their isolation. In fact, conventional approaches are characterized by low purity and throughput, or poor reproducibility. Here, we present a droplet microfluidic platform specifically developed for EV isolation by affinity capture with magnetic beads. This platform is capable of processing large sample volumes (2 mL) in a relatively short time (4.5 hours), with considerable automation. In detail, EVs and magnetic beads are co-encapsulated within the same droplet, which acts promoting their mixing due to the spontaneous recirculation; this continuous agitation prevents any loss usually caused by bead sedimentation and promotes the EV capturing. Our droplet microfluidic protocol is compared to a commercially available method, showing a shorter required incubation time (about 2.5 times) and a higher capture efficiency (2.5-folds). The microfluidic approach is therefore positively evaluated in terms of protein content, EV quantification and microRNA cargo analysis.

Droplet microfluidic platform for extracellular vesicle isolation based on magnetic bead handling

Meggiolaro A.;Moccia V.;Sammarco A.;Brun P.;Crestani B.;Mussolin L.;Pierno M.;Mistura G.;Zappulli V.;Ferraro D.
2024

Abstract

Extracellular vesicles (EVs) are rapidly gaining in popularity as biomarkers of various diseases, acting as cargoes of valuable information from the cell of origin. Despite their important value, their current use in clinical practice is still limited. One of the most limiting factors is their isolation. In fact, conventional approaches are characterized by low purity and throughput, or poor reproducibility. Here, we present a droplet microfluidic platform specifically developed for EV isolation by affinity capture with magnetic beads. This platform is capable of processing large sample volumes (2 mL) in a relatively short time (4.5 hours), with considerable automation. In detail, EVs and magnetic beads are co-encapsulated within the same droplet, which acts promoting their mixing due to the spontaneous recirculation; this continuous agitation prevents any loss usually caused by bead sedimentation and promotes the EV capturing. Our droplet microfluidic protocol is compared to a commercially available method, showing a shorter required incubation time (about 2.5 times) and a higher capture efficiency (2.5-folds). The microfluidic approach is therefore positively evaluated in terms of protein content, EV quantification and microRNA cargo analysis.
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0925400524003125-main.pdf

accesso aperto

Tipologia: Published (publisher's version)
Licenza: Creative commons
Dimensione 4.77 MB
Formato Adobe PDF
4.77 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11577/3514526
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 6
  • OpenAlex ND
social impact